| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.8M | -35.7% |
| R&D Expense | $164.2M | +19.9% |
| SG&A Expense | $43.8M | +20.6% |
| Operating Income | -$161.3M | -60.4% |
| Income Tax | $0 | — |
| Net Income | -$154.8M | -54.5% |
| EPS (Basic) | -$2.87 | -37.3% |
| EPS (Diluted) | -$2.87 | -37.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.4M | +42.6% |
| Current Assets | $419.4M | -7.1% |
| Total Assets | $603.1M | -0.5% |
| Current Liabilities | $71.3M | -22.9% |
| Total Liabilities | $113.0M | -22.8% |
| Stockholders' Equity | $490.2M | +6.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$153.1M | -18.7% |
| Capital Expenditures | $2.8M | +77.6% |
| Investing Cash Flow | $20.5M | +120.6% |
| Financing Cash Flow | $153.0M | -38.9% |
| Free Cash Flow | -$155.9M | -19.4% |